Home › Myositis › Pennsylvania › Pittsburgh
Myositis clinical trials in Pittsburgh, PA
3 studies for Myositis are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
RecruitingPhase 2
- University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RecruitingPhase 3
- UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh
- UPMC Montefiore Clinical and Translational Research Center (CTRC), Pittsburgh
- UPMC Presbyterian Shadyside Hospital, Pittsburgh
About Myositis
Myositis means inflammation of the muscles. Two specific types are polymyositis and dermatomyositis. Read about myositis symptoms and management.
More about Myositis on MedlinePlus
Myositis trials in other cities
- Durham, NC10 studies
- Boston, MA6 studies
- New York City, NY6 studies
- Miami, FL5 studies
- Chicago, IL5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Cedar Rapids, IA4 studies
- Baltimore, MD4 studies
- Plantation, FL3 studies
- Phoenix, AZ3 studies
- Jacksonville, FL3 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)42 studies
- Breast Cancer42 studies
- Ovarian Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Endometrial Cancer24 studies
- Lung Cancer24 studies
- Head and Neck Squamous Cell Carcinoma23 studies
- Prostate Cancer23 studies
- Depression22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.